A child has phocomelia. This is due to drug taken by mother aEUR’
**Core Concept**
Phocomelia is a rare congenital anomaly characterized by the absence or severe underdevelopment of limbs, typically affecting the upper limbs more than the lower limbs. This condition is often associated with exposure to a specific teratogenic agent during pregnancy.
**Why the Correct Answer is Right**
The correct answer is related to the drug thalidomide, which was widely used as a sedative and antihistamine in the late 1950s and early 1960s. Thalidomide crosses the placental barrier and interferes with limb development, leading to phocomelia. The mechanism involves the inhibition of angiogenesis and the disruption of the normal development of limb buds. Thalidomide acts on the vascular endothelial growth factor (VEGF) pathway, which is crucial for the formation of new blood vessels and the development of limbs.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because thalidomide is the primary teratogen associated with phocomelia, not valproate. Valproate is a different antiepileptic medication that can cause fetal hydantoin syndrome, which is characterized by different birth defects.
* **Option B:** This option is incorrect because corticosteroids are not known to cause phocomelia. While corticosteroids can have teratogenic effects, they are more commonly associated with other types of birth defects, such as cleft palate or cardiac anomalies.
* **Option C:** This option is incorrect because alcohol exposure during pregnancy can cause fetal alcohol spectrum disorder (FASD), which includes a range of birth defects and developmental disabilities, but not specifically phocomelia.
* **Option D:** This option is incorrect because there is no established association between isoniazid and phocomelia. Isoniazid is an antituberculosis medication that can have teratogenic effects, but it is not specifically linked to phocomelia.
**Clinical Pearl / High-Yield Fact**
The thalidomide disaster led to a significant change in the way drugs are tested for teratogenicity during pregnancy. Today, all new medications are required to undergo rigorous testing for safety in pregnant animals before they are approved for use in humans.
**Correct Answer:** D.